We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
+7.08%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$382M
AUM Growth
-$30.1M
Cap. Flow
-$47M
Cap. Flow %
-12.33%
Top 10 Hldgs %
51.73%
Holding
167
New
4
Increased
5
Reduced
49
Closed
9

Top Sells

Rank Stock Value
1
PAYC icon
Paycom
PAYC
+$11.6M
2
ENOV icon
Enovis
ENOV
+$10.3M
3
LFUS icon
Littelfuse
LFUS
+$8.42M
4
AAPL icon
Apple
AAPL
+$7.56M
5
ALB icon
Albemarle
ALB
+$6.79M

Sector Composition

Rank Sector Weight
1 Technology 32.94%
2 Financials 16.29%
3 Healthcare 14.38%
4 Consumer Staples 9.86%
5 Communication Services 7.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSCO icon
26
Cisco
CSCO
$475B
$3.65M 0.96%
52,562
-1,625
-3% -$99.9K
MSFT icon
27
Microsoft
MSFT
$3.74T
$3.39M 0.89%
6,810
CRM icon
28
Salesforce
CRM
$162B
$3.18M 0.83%
11,676
-278
-2% -$74.3K
CVX icon
29
Chevron
CVX
$386B
$2.91M 0.76%
20,300
JPM icon
30
JPMorgan Chase
JPM
$962B
$2.58M 0.68%
8,903
-125
-1% -$31.9K
ABBV icon
31
AbbVie
ABBV
$442B
$1.77M 0.46%
9,537
SHEL icon
32
Shell
SHEL
$250B
$1.72M 0.45%
24,423
-800
-3% -$53.6K
RITM.PRB icon
33
Rithm Capital Corp 7.125% Series B Preferred Stock
RITM.PRB
$284M
$1.72M 0.45%
67,491
HXL icon
34
Hexcel
HXL
$7.6B
$1.53M 0.4%
27,056
-1,642
-6% -$86.8K
VRSN icon
35
VeriSign
VRSN
$26B
$1.44M 0.38%
4,995
SCHW
36
Charles Schwab
SCHW
$186B
$1.36M 0.36%
14,907
-50
-0.3% -$4.19K
XOM icon
37
ExxonMobil
XOM
$657B
$1.19M 0.31%
11,083
-733
-6% -$78.4K
T.PRA icon
38
AT&T Series A
T.PRA
$859M
$1.19M 0.31%
59,300
+20,000
+51% +$398K
WFC.PRL icon
39
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
$1.04M 0.27%
887
COF.PRI icon
40
Capital One Financial Series I Preferred Stock
COF.PRI
$1.07B
$894K 0.23%
47,400
+23,700
+100% +$443K
IBM icon
41
IBM
IBM
$225B
$887K 0.23%
3,008
EW icon
42
Edwards Lifesciences
EW
$54B
$823K 0.22%
10,525
-200
-2% -$14.9K
ABT icon
43
Abbott
ABT
$190B
$804K 0.21%
5,910
AGNCO icon
44
AGNC Investment Dep Shares 1/1000 Cumulative Series E
AGNCO
$796K 0.21%
31,324
RITM.PRD icon
45
Rithm Capital Corp 7.00% Series D Preferred Stock
RITM.PRD
$465M
$747K 0.2%
31,200
+16,500
+112% +$394K
WMT icon
46
Walmart Inc
WMT
$901B
$733K 0.19%
7,500
GILD icon
47
Gilead Sciences
GILD
$168B
$698K 0.18%
6,294
-1,775
-22% -$189K
BRK.B icon
48
Berkshire Hathaway Class B
BRK.B
$1.11T
$675K 0.18%
1,389
KIM icon
49
Kimco Realty
KIM
$16.1B
$596K 0.16%
28,350
BAC icon
50
Bank of America
BAC
$448B
$561K 0.15%
11,846
-1,300
-10% -$54.7K

Similar funds

Kelly Lawrence W & Associates's Q2 2025 Portfolio in Review

As of Q2 2025, Kelly Lawrence W & Associates held 167 positions worth $382M, down 7.3% from $412M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Kelly Lawrence W & Associates withdrew a net $47M in Q2 2025, closing 9 positions and reducing 49 holdings. Its most notable exit was Paycom, an estimated $11.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 37% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Kelly Lawrence W & Associates opened a new position in UnitedHealth worth $12.1M.

  • Kelly Lawrence W & Associates's largest Q2 2025 buy was UnitedHealth: 38,790 shares worth $12.1M.
  • Kelly Lawrence W & Associates added most to Capital One Financial Series I Preferred Stock in Q2 2025, an estimated $443K increase.
  • Kelly Lawrence W & Associates's biggest Q2 2025 reduction was Littelfuse, cutting an estimated $8.42M.
  • Kelly Lawrence W & Associates fully exited Paycom in Q2 2025, selling an estimated $11.6M.
  • Kelly Lawrence W & Associates's ten largest holdings make up 52% of its $382M portfolio in Q2 2025.
  • Kelly Lawrence W & Associates opened 4 new positions and closed 9 in Q2 2025.
  • Kelly Lawrence W & Associates's portfolio value fell 7.3% quarter-over-quarter to $382M.

Based on Kelly Lawrence W & Associates's 13F filing for Q2 2025, filed 14 Aug 2025.